<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="zh">
	<id>https://arolstar52-zhtest.hf.space/index.php?action=history&amp;feed=atom&amp;title=SL-164</id>
	<title>SL-164 - 版本历史</title>
	<link rel="self" type="application/atom+xml" href="https://arolstar52-zhtest.hf.space/index.php?action=history&amp;feed=atom&amp;title=SL-164"/>
	<link rel="alternate" type="text/html" href="https://arolstar52-zhtest.hf.space/index.php?title=SL-164&amp;action=history"/>
	<updated>2026-07-17T21:02:42Z</updated>
	<subtitle>在这个wiki上该页的修订历史</subtitle>
	<generator>MediaWiki 1.43.9</generator>
	<entry>
		<id>https://arolstar52-zhtest.hf.space/index.php?title=SL-164&amp;diff=4631022&amp;oldid=prev</id>
		<title>imported&gt;Htmlzycq：​使用HotCat已添加Category:GABAA受体正向变构调节剂</title>
		<link rel="alternate" type="text/html" href="https://arolstar52-zhtest.hf.space/index.php?title=SL-164&amp;diff=4631022&amp;oldid=prev"/>
		<updated>2025-04-30T02:46:03Z</updated>

		<summary type="html">&lt;p&gt;使用&lt;a href=&quot;/index.php?title=WP:HOTCAT&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;WP:HOTCAT（页面不存在）&quot;&gt;HotCat&lt;/a&gt;已添加&lt;a href=&quot;/wiki/Category:GABAA%E5%8F%97%E4%BD%93%E6%AD%A3%E5%90%91%E5%8F%98%E6%9E%84%E8%B0%83%E8%8A%82%E5%89%82&quot; title=&quot;Category:GABAA受体正向变构调节剂&quot;&gt;Category:GABAA受体正向变构调节剂&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;新页面&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Infobox drug&lt;br /&gt;
| IUPAC_name = 5-chloro-3-(4-chloro-2-methylphenyl)-2-methylquinazolin-4-one&lt;br /&gt;
| image = SL-164.svg&lt;br /&gt;
| width = 200&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Clinical data--&amp;gt;&lt;br /&gt;
| tradename =  &lt;br /&gt;
| pregnancy_AU = &amp;lt;!-- A / B1 / B2 / B3 / C / D / X --&amp;gt;&lt;br /&gt;
| pregnancy_US = &amp;lt;!-- A / B            / C / D / X --&amp;gt;&lt;br /&gt;
| pregnancy_category =  &lt;br /&gt;
| legal_AU = &amp;lt;!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --&amp;gt;&lt;br /&gt;
| legal_CA = &amp;lt;!--             / Schedule I, II, III, IV, V, VI, VII, VIII --&amp;gt;&lt;br /&gt;
| legal_UK = &amp;lt;!-- GSL         / P       / POM / CD / Class A, B, C --&amp;gt;&lt;br /&gt;
| legal_US = &amp;lt;!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V --&amp;gt;&lt;br /&gt;
| legal_status =  &lt;br /&gt;
| routes_of_administration =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Pharmacokinetic data--&amp;gt;&lt;br /&gt;
| bioavailability =  &lt;br /&gt;
| protein_bound =  &lt;br /&gt;
| metabolism =  &lt;br /&gt;
| elimination_half-life =  &lt;br /&gt;
| excretion =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Identifiers--&amp;gt;&lt;br /&gt;
| CAS_number_Ref = {{cascite|correct|CAS}}&lt;br /&gt;
| CAS_number = 3476-88-8&lt;br /&gt;
| UNII_Ref = {{fdacite|correct|FDA}}&lt;br /&gt;
| UNII = KQ54T3QL7X&lt;br /&gt;
| ATC_prefix = none&lt;br /&gt;
| ATC_suffix =  &lt;br /&gt;
| PubChem = 63386&lt;br /&gt;
| ChemSpiderID      = 57049&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Chemical data--&amp;gt;&lt;br /&gt;
| C=16 | H=12 | Cl=2 | N=2 | O=1 &lt;br /&gt;
| smiles = ClC1=CC(C)=C(N2C(C)=NC3=CC=CC(Cl)=C3C2=O)C=C1&lt;br /&gt;
| StdInChI          = 1S/C16H12Cl2N2O/c1-9-8-11(17)6-7-14(9)20-10(2)19-13-5-3-4-12(18)15(13)16(20)21/h3-8H,1-2H3&lt;br /&gt;
| StdInChIKey       = KUIHLOHNUGOCTO-UHFFFAOYSA-N&lt;br /&gt;
}}&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;{{PAGENAME}}&amp;#039;&amp;#039;&amp;#039;是一种[[氮化合物|含氮]][[有机氯化合物]]，分子式[[C16H12Cl2N2O|{{chem2|C16H12Cl2N2O}}]]，为[[安眠酮]]的[[结构类似物]]，1960年代由[[住友集团]]的科研团队开发&amp;lt;ref&amp;gt;{{cite patent | country = US | number = 3651230 | title = Compositions And Methods For Tranquilizing With Substituted 3-Phenyl-4-Quinazolinone Derivatives }}&amp;lt;/ref&amp;gt;。&lt;br /&gt;
&lt;br /&gt;
==参考文献==&lt;br /&gt;
{{reflist}}&lt;br /&gt;
&lt;br /&gt;
[[Category:镇静药]]&lt;br /&gt;
[[Category:喹唑啉酮]]&lt;br /&gt;
[[Category:GABAA受体正向变构调节剂]]&lt;/div&gt;</summary>
		<author><name>imported&gt;Htmlzycq</name></author>
	</entry>
</feed>